F M Investments LLC Cuts Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

F M Investments LLC trimmed its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 33.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,751 shares of the pharmacy operator’s stock after selling 19,874 shares during the period. F M Investments LLC’s holdings in Walgreens Boots Alliance were worth $356,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of WBA. FinTrust Capital Advisors LLC increased its position in shares of Walgreens Boots Alliance by 60.4% during the first quarter. FinTrust Capital Advisors LLC now owns 2,130 shares of the pharmacy operator’s stock worth $46,000 after purchasing an additional 802 shares in the last quarter. Redwood Investment Management LLC grew its holdings in shares of Walgreens Boots Alliance by 0.9% during the first quarter. Redwood Investment Management LLC now owns 99,661 shares of the pharmacy operator’s stock worth $2,162,000 after buying an additional 850 shares in the last quarter. Empirical Finance LLC raised its position in shares of Walgreens Boots Alliance by 3.5% in the first quarter. Empirical Finance LLC now owns 26,093 shares of the pharmacy operator’s stock valued at $566,000 after buying an additional 888 shares during the last quarter. Inlet Private Wealth LLC lifted its stake in shares of Walgreens Boots Alliance by 1.9% in the second quarter. Inlet Private Wealth LLC now owns 47,820 shares of the pharmacy operator’s stock worth $578,000 after buying an additional 900 shares in the last quarter. Finally, Capital Investment Counsel Inc boosted its position in Walgreens Boots Alliance by 6.6% during the second quarter. Capital Investment Counsel Inc now owns 15,340 shares of the pharmacy operator’s stock worth $186,000 after acquiring an additional 950 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on WBA shares. Truist Financial decreased their target price on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research note on Monday, October 7th. Evercore ISI boosted their price objective on Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a research note on Wednesday, October 16th. TD Cowen cut their target price on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a research note on Tuesday, October 22nd. Bank of America lowered their price target on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a research report on Wednesday, September 4th. Finally, Jefferies Financial Group reduced their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research note on Wednesday, October 23rd. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $12.88.

Walgreens Boots Alliance Price Performance

NASDAQ:WBA opened at $9.46 on Monday. Walgreens Boots Alliance, Inc. has a 52 week low of $8.22 and a 52 week high of $27.05. The stock’s fifty day moving average is $9.20 and its two-hundred day moving average is $12.44. The stock has a market capitalization of $8.18 billion, a price-to-earnings ratio of -0.95, a price-to-earnings-growth ratio of 1.24 and a beta of 0.68. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.03. The firm had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. Walgreens Boots Alliance’s revenue was up 5.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.67 EPS. Research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Investors of record on Monday, November 18th will be issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 10.57%. The ex-dividend date of this dividend is Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently -9.99%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.